|
|
|
|
LEADER |
07219cam a2201081 i 4500 |
001 |
950971641 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
160601s2016 gw a ob 000 0 eng d |
019 |
|
|
|a 951223267
|a 953613404
|a 1011894656
|a 1127132175
|a 1155931985
|
020 |
|
|
|a 9783658127947
|q (electronic bk.)
|
020 |
|
|
|a 3658127945
|q (electronic bk.)
|
020 |
|
|
|a 3658127937
|
020 |
|
|
|a 9783658127930
|
020 |
|
|
|z 9783658127930
|q (print)
|
024 |
7 |
|
|a 10.1007/978-3-658-12794-7
|2 doi
|
035 |
|
|
|a (OCoLC)950971641
|z (OCoLC)951223267
|z (OCoLC)953613404
|z (OCoLC)1011894656
|z (OCoLC)1127132175
|z (OCoLC)1155931985
|
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d YDXCP
|d GW5XE
|d AZU
|d EBLCP
|d IDEBK
|d OCLCF
|d N$T
|d KSU
|d VT2
|d IAD
|d JBG
|d ICW
|d Z5A
|d ILO
|d ICN
|d OCLCQ
|d ESU
|d CASUM
|d OCLCO
|d IOG
|d OCLCA
|d U3W
|d MERUC
|d OCLCO
|d OCLCA
|d EZ9
|d OCLCQ
|d WYU
|d OCLCO
|d COO
|d REB
|d OCLCA
|d AUD
|d OCLCO
|d OCLCQ
|d UKAHL
|d OCLCQ
|d OCLCA
|d SFB
|d OCLCA
|d AJS
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCL
|
049 |
|
|
|a COM6
|
050 |
|
4 |
|a RC280.S5
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
072 |
|
7 |
|a MJK
|2 bicssc
|
082 |
0 |
4 |
|a 616.99/477042
|2 23
|
100 |
1 |
|
|a Sand, Michael,
|e author.
|
245 |
1 |
0 |
|a MicroRNAs in malignant tumors of the skin :
|b first steps of tiny players in the skin to a new world of genomic medicine /
|c Michael Sand.
|
264 |
|
1 |
|a Wiesbaden :
|b Springer,
|c 2016.
|
300 |
|
|
|a 1 online resource (xi, 245 pages) :
|b color illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent.
|
337 |
|
|
|a computer
|b c
|2 rdamedia.
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier.
|
490 |
0 |
|
|a Research.
|
504 |
|
|
|a Includes bibliographical references.
|
588 |
0 |
|
|a Online resource; title from PDF title page (SpringerLink, viewed June 13, 2016).
|
505 |
0 |
|
|a Introduction -- Objectives of this work -- Summary and discussion of this work -- Closing remarks -- Paper 1: Expression levels of the microRNA processing enzymes Drosha and Dicer in epithelial skin cancer -- Paper 2: Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA- induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1 and TARBP2 in epithelial skin cancer -- Paper 3: Expression of microRNAs in basal cell carcinoma -- Paper 4: Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma -- Paper 5: The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi -- Paper 6: Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi -- Paper 7: Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi -- Paper 8: MicroRNAs and the skin: tiny players in the body's largest organ -- Paper 9: microRNA in non-melanoma skin cancer.
|
520 |
|
|
|a Michael Sand gives the reader an overview of current techniques in expression profiling of miRNAs and their maturation machinery in the skin. This book is a postdoctoral thesis on miRNAs in cutaneous malignant melanoma and non-melanoma skin cancer with a focus on the miRNA processing machinery and miRNA expression profiling. The research presented in this book was performed in the Dermatologic Surgery Section at the Department of Dermatology, Venereology and Allergology of the Ruhr-University Bochum, Germany and gives the reader an overview of current techniques in expression profiling of miRNAs and their maturation machinery in the skin. Contents MicroRNAS Basal cell carcinoma Cutaneous squamous cell carcinoma Cutaneous malignant melanoma Target Groups Researchers and students in the field of medicine, dermatology, molecular biology, pathology Dermatologist and pathologist About the Author Michael Sand, MD studied medicine at the Ruhr-University of Bochum / Germany, Harvard Medical School Boston and the University of California, San Diego (UCSD). After board certification in Dermatology, Venereology and Emergency Medicine at the Ruhr-University Bochum / Germany he and his team started to investigate the role of microRNA in the skin. He is currently an attending physician in the Department of Plastic Surgery, Catholic Clinics of the Ruhr Peninsula, Essen, Germany with a clinical focus on surgical therapy of skin cancer and a research focus on the role of microRNAs in malignant skin tumors.
|
650 |
|
0 |
|a Skin
|x Cancer
|x Genetic aspects.
|
650 |
|
0 |
|a RNA.
|
650 |
|
0 |
|a MicroRNA.
|
650 |
|
0 |
|a Genomics.
|
650 |
1 |
2 |
|a MicroRNAs.
|
650 |
1 |
2 |
|a Skin Neoplasms
|x genetics.
|
650 |
|
2 |
|a RNA.
|
650 |
2 |
2 |
|a Genomics.
|
650 |
|
6 |
|a ARN.
|
650 |
|
6 |
|a MicroARN.
|
650 |
|
6 |
|a Génomique.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh.
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh.
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh.
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh.
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh.
|
650 |
|
7 |
|a MicroRNA.
|2 fast.
|
650 |
|
7 |
|a Genomics.
|2 fast.
|
650 |
|
7 |
|a RNA.
|2 fast.
|
650 |
|
7 |
|a Skin
|x Cancer
|x Genetic aspects.
|2 fast.
|
655 |
|
0 |
|a Electronic books.
|
655 |
|
4 |
|a Internet Resources.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
776 |
0 |
8 |
|i Print version:
|a Sand, PD Dr. Michael.
|t MicroRNAs in malignant tumors of the skin : First steps of tiny players in the skin to a new world of genomic medicine.
|d Wiesbaden : Springer Fachmedien Wiesbaden, ©2016
|z 9783658127930.
|
907 |
|
|
|a .b50879364
|b multi
|c -
|d 160706
|e 240701
|
998 |
|
|
|a (3)cue
|a cu
|b 240404
|c m
|d z
|e -
|f eng
|g gw
|h 0
|i 2
|
948 |
|
|
|a MARCIVE Overnight, in 2024.04
|
948 |
|
|
|a MARCIVE Overnight, in 2023.01
|
948 |
|
|
|a MARCIVE Over, 07/2021
|
948 |
|
|
|a MARCIVE Comp, 2019.12
|
948 |
|
|
|a MARCIVE Comp, 2018.05
|
948 |
|
|
|a MARCIVE August, 2017
|
948 |
|
|
|a MARCIVE extract Aug 5, 2017
|
933 |
|
|
|a Marcive found issue: "490 0
|a Research."
|
994 |
|
|
|a 92
|b COM
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2024.04
|
995 |
|
|
|a Loaded with m2btab.elec in 2024.04
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2023.01
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2021.07
|
995 |
|
|
|a Loaded with m2btab.elec in 2021.06
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2019.12
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2018.06
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2017.09
|
995 |
|
|
|a Loaded with m2btab.elec in 2016
|
995 |
|
|
|a Loaded with m2btab.elec in 2016
|
995 |
|
|
|a Loaded with m2btab.elec in 2016
|
995 |
|
|
|a OCLC offline update by CMU
|
995 |
|
|
|a Loaded with m2btab.auth in 2021.07
|
995 |
|
|
|a Loaded with m2btab.auth in 2024.06
|
999 |
|
|
|e z
|
999 |
|
|
|a cue
|
989 |
|
|
|d cueme
|e - -
|f - -
|g -
|h 0
|i 0
|j 200
|k 240404
|l $0.00
|m
|n - -
|o -
|p 0
|q 0
|t 0
|x 0
|w SpringerLink
|1 .i15145792x
|u http://ezproxy.coloradomesa.edu/login?url=https://link.springer.com/10.1007/978-3-658-12794-7
|3 SpringerLink
|z Click here for access
|